ReneuRxTM

Our goal with ReneuRx therapy is to deliver a quantum leap in pain control.

ReneuRx™ therapy is intended to result in long lasting desensitization of pain in a targeted area. Animal models have demonstrated that reduction in pain can potentially last 3 months or more.

With one treatment, relief can be highly targeted and may result in significant pain relief.

The “ReneuRx™ solution’s enduring pain control has the potential to last orders of magnitude longer than current methods of local anesthesia”
-Sameer Sabir, CEO, Brixton Biosciences
Brixton logo
TechnologyAboutTeamNICETM Clinical TrialNewsContact
©2025 Brixton Biosciences. All rights reserved. Version 1.15 | Privacy Policy | Terms of Use | FCOI Policy
This website describes our product, which has not been approved or cleared for marketing by the U.S. Food and Drug Administration and is considered an investigational device.